Aurora Cannabis Inc vs Devon Energy Corp — how do they compare? Aurora Cannabis Inc trades at $3.49 (market cap $178.92M), while Devon Energy Corp trades at $45.13 (market cap $49.90B). The key difference: Devon Energy Corp is far larger — about 278.9× Aurora Cannabis Inc's market cap, and Devon Energy Corp pays a 2.82% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | DVN | |
|---|---|---|
Market Cap | $178.92M | $49.90B |
Sector | Health | Energy |
52-Week High | $6.23 | $52.07 |
52-Week Low | $2.58 | $31.74 |
Enterprise Value | $123.48M | $60.63B |
Dividend Yield | — | 2.82% |
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.99, up 0.34% with a bullish technical signal despite mixed earnings. The company achieved record annual medical cannabis revenue growth of 18% YoY to $288.6 million in FY2026, but faces margin pressure from Canadian reimbursement changes. Recent Q1 2027 earnings beat expectations with $0.04 EPS versus -$0.13 estimate, though revenue declined to $67.6 million. The stock shows strong institutional support with shareholder approval of board measures and EU-GMP certification for international expansion.
ACB presents a high-risk opportunity with significant volatility. While international medical cannabis growth and operational improvements provide upside potential, persistent net losses, negative ROE/ROA, and Canadian market challenges create substantial headwinds. Analyst consensus remains cautious with only 21% buy ratings, reflecting concerns about profitability timeline and competitive pressures in the evolving cannabis sector.
Devon Energy (DVN) trades at $42.98, down 0.3% with a bearish technical signal. The company reported strong Q2 2026 results, beating EPS estimates by 21% and revenue by 18%, while raising its dividend 33% and accelerating debt reduction. Valuation metrics appear attractive with P/E of 9.34 and EV/EBITDA of 6.59, though net income margins have declined from 31.4% in 2022 to 15.4% in 2025.
The outlook remains positive with 71% analyst buy ratings and a $61.91 consensus price target representing 44% upside. Key catalysts include merger synergies from Coterra integration and strong free cash flow generation supporting shareholder returns. Risks include oil price volatility and execution of the $1B+ synergy target by 2027.
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →